Literature DB >> 20518765

Partial nephrectomy for selected renal cortical tumours of ≥ 7 cm.

Michael E Karellas1, M Frank O'Brien, Thomas L Jang, Melanie Bernstein, Paul Russo.   

Abstract

OBJECTIVE: To examine our institutional experience in patients treated with partial nephrectomy (PN) for renal cortical tumours (RCTs) of ≥ 7 cm, as PN is an accepted surgical approach for appropriate RCTs of < 7 cm but there are limited data on the use of PN for larger tumours. PATIENTS AND METHODS: After Institutional Review Board approval, we examined our prospectively collected surgical database for patients treated with PN for RCTs of ≥ 7 cm between 1989 and 2008. Pertinent demographic, clinical, surgical and pathological data were reviewed.
RESULTS: In all, 34 patients (37 renal units) were identified for analysis with a median (interquartile range, IQR) age of 63 (52-71) years, median (IQR) tumour size of 7.5 (7.2-9.0) cm with the largest tumour being 19 cm. In 31 renal units (28 patients, 84%) carcinoma was evident, with 16 renal units (43%) having conventional clear cell carcinoma, followed by papillary in eight renal units (21%). Currently, 20 of these 28 patients (71%) are disease free, three are alive with metastatic disease (two had known preoperative metastatic disease), three died from disease and two died from other causes. The median (IQR) preoperative estimated glomerular filtration rate was 65 (55-73) mL/min/1.73 m(2) , compared with 55 (47-74) mL/min/1.73 m(2) after PN (P= 0.003, paired Student's t-test).
CONCLUSIONS: Our findings suggest that PN for RCTs of ≥ 7 cm can be safely performed and provide effective tumour control for selected patients. PN should be considered for patients with appropriate tumours, solitary kidneys or pre-existing renal insufficiency.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20518765      PMCID: PMC4319322          DOI: 10.1111/j.1464-410X.2010.09405.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  15 in total

1.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Authors:  William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

2.  Contemporary understanding and management of renal cortical tumors.

Authors:  Paul Russo
Journal:  Urol Clin North Am       Date:  2008-11       Impact factor: 2.241

3.  Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm.

Authors:  Atreya Dash; Andrew J Vickers; Lee R Schachter; Ariadne M Bach; Mark E Snyder; Paul Russo
Journal:  BJU Int       Date:  2006-05       Impact factor: 5.588

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Use of nephrectomy at select medical centers--a case of follow the crowd?

Authors:  Brent K Hollenbeck; David A Taub; David C Miller; Rodney L Dunn; John T Wei
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

6.  Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.

Authors:  Mark E Snyder; Ariadne Bach; Michael W Kattan; Ganesh V Raj; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

7.  Tumor size is associated with malignant potential in renal cell carcinoma cases.

Authors:  R Houston Thompson; Jordan M Kurta; Matthew Kaag; Satish K Tickoo; Shilajit Kundu; Darren Katz; Lucas Nogueira; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

8.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

Review 9.  The genetic basis of cancer of the kidney.

Authors:  W Marston Linehan; McClellan M Walther; Berton Zbar
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

10.  Risk factors and management of urine leaks after partial nephrectomy.

Authors:  Joshua J Meeks; Lee C Zhao; Neema Navai; Kent T Perry; Robert B Nadler; Norm D Smith
Journal:  J Urol       Date:  2008-10-18       Impact factor: 7.450

View more
  16 in total

1.  Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors.

Authors:  Daniel Canter; Alexander Kutikov; Mohit Sirohi; Ryan Street; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo
Journal:  Urology       Date:  2011-02-12       Impact factor: 2.649

2.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 3.  Contemporary Experience with Partial Nephrectomy for Stage T2 or Greater Renal Tumors.

Authors:  Shaheen Alanee; Michelle Herberts; Bradley Holland; Danuta Dynda
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

4.  Partial nephrectomy for T2 renal masses: contemporary trends and oncologic efficacy.

Authors:  Shaheen Alanee; Max Nutt; Aaron Moore; Bradley Holland; Danuta Dynda; Andrew Wilber; Ahmed El-Zawahry
Journal:  Int Urol Nephrol       Date:  2015-04-12       Impact factor: 2.370

5.  Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience.

Authors:  Ercan Malkoc; Daniel Ramirez; Onder Kara; Matthew J Maurice; Ryan J Nelson; Peter A Caputo; Jihad H Kaouk
Journal:  World J Urol       Date:  2016-09-23       Impact factor: 4.226

Review 6.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

Review 7.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04

8.  Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis.

Authors:  Ruizhen Huang; Chiyu Zhang; Xing Wang; Honglin Hu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

9.  Ischemic preconditioning increases endothelial progenitor cell number to attenuate partial nephrectomy-induced ischemia/reperfusion injury.

Authors:  Hao Liu; Ran Wu; Rui-Peng Jia; Bing Zhong; Jia-Geng Zhu; Peng Yu; Yan Zhao; Yu-Zheng Ge; Jian-Ping Wu
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Nephron-Sparing Surgery for Renal Masses Measuring Larger Than 7 cm on Preoperative Imaging: A Single Surgeon, Single Center Experience.

Authors:  Tarık Esen; Omer Acar; Ahmet Musaoğlu; Metin Vural; Sergin Akpek
Journal:  ISRN Surg       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.